| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 110 | 2024 | 507 | 19.450 |
Why?
|
| Arthroscopy | 111 | 2023 | 549 | 17.270 |
Why?
|
| Rotator Cuff Injuries | 61 | 2024 | 223 | 15.230 |
Why?
|
| Rotator Cuff | 56 | 2024 | 209 | 10.900 |
Why?
|
| Joint Instability | 49 | 2023 | 309 | 10.640 |
Why?
|
| Tenodesis | 40 | 2023 | 137 | 10.030 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 38 | 2022 | 137 | 8.490 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 32 | 2022 | 187 | 7.250 |
Why?
|
| Humans | 373 | 2024 | 23331 | 6.860 |
Why?
|
| Baseball | 22 | 2023 | 91 | 6.700 |
Why?
|
| Tendon Injuries | 29 | 2022 | 153 | 6.200 |
Why?
|
| Shoulder | 38 | 2024 | 140 | 6.100 |
Why?
|
| Anterior Cruciate Ligament Injuries | 29 | 2023 | 142 | 5.940 |
Why?
|
| Shoulder Injuries | 26 | 2022 | 112 | 5.620 |
Why?
|
| Anterior Cruciate Ligament | 35 | 2022 | 134 | 5.610 |
Why?
|
| Orthopedic Procedures | 29 | 2023 | 227 | 5.420 |
Why?
|
| Knee Joint | 53 | 2023 | 572 | 5.240 |
Why?
|
| Patient Reported Outcome Measures | 40 | 2024 | 311 | 5.190 |
Why?
|
| Shoulder Dislocation | 19 | 2022 | 87 | 5.140 |
Why?
|
| Range of Motion, Articular | 78 | 2024 | 569 | 5.030 |
Why?
|
| Treatment Outcome | 112 | 2024 | 2988 | 4.760 |
Why?
|
| Adult | 148 | 2023 | 7070 | 4.610 |
Why?
|
| Middle Aged | 148 | 2022 | 8055 | 4.510 |
Why?
|
| Muscle, Skeletal | 31 | 2022 | 323 | 4.430 |
Why?
|
| Athletic Injuries | 19 | 2022 | 126 | 4.240 |
Why?
|
| Male | 181 | 2022 | 12629 | 3.950 |
Why?
|
| Suture Anchors | 14 | 2023 | 56 | 3.860 |
Why?
|
| Tendons | 26 | 2023 | 167 | 3.760 |
Why?
|
| Retrospective Studies | 85 | 2023 | 3040 | 3.730 |
Why?
|
| Knee Injuries | 25 | 2023 | 125 | 3.620 |
Why?
|
| Return to Sport | 17 | 2023 | 100 | 3.490 |
Why?
|
| Female | 162 | 2023 | 13124 | 3.460 |
Why?
|
| Postoperative Complications | 31 | 2022 | 836 | 3.020 |
Why?
|
| Cadaver | 44 | 2023 | 275 | 2.960 |
Why?
|
| Tibia | 17 | 2020 | 198 | 2.910 |
Why?
|
| Femur | 15 | 2020 | 304 | 2.910 |
Why?
|
| Elbow Joint | 15 | 2023 | 114 | 2.850 |
Why?
|
| Young Adult | 58 | 2023 | 1674 | 2.830 |
Why?
|
| Biomechanical Phenomena | 51 | 2023 | 524 | 2.780 |
Why?
|
| Cartilage, Articular | 14 | 2023 | 266 | 2.730 |
Why?
|
| Collateral Ligament, Ulnar | 9 | 2023 | 26 | 2.630 |
Why?
|
| Upper Extremity | 13 | 2022 | 51 | 2.630 |
Why?
|
| Glenoid Cavity | 8 | 2022 | 29 | 2.600 |
Why?
|
| Minimal Clinically Important Difference | 16 | 2022 | 83 | 2.570 |
Why?
|
| Bone Screws | 14 | 2023 | 122 | 2.480 |
Why?
|
| Aged | 78 | 2021 | 7552 | 2.430 |
Why?
|
| Adolescent | 56 | 2023 | 1916 | 2.420 |
Why?
|
| Tendinopathy | 9 | 2022 | 34 | 2.310 |
Why?
|
| Orthopedics | 7 | 2020 | 88 | 2.260 |
Why?
|
| Sports Medicine | 7 | 2022 | 25 | 2.230 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2023 | 880 | 2.190 |
Why?
|
| Bone Transplantation | 15 | 2023 | 153 | 2.140 |
Why?
|
| Scapula | 15 | 2021 | 77 | 2.120 |
Why?
|
| Arthroplasty | 14 | 2020 | 105 | 2.030 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2020 | 593 | 2.030 |
Why?
|
| Osteoarthritis | 13 | 2020 | 279 | 1.990 |
Why?
|
| Tibial Meniscus Injuries | 6 | 2022 | 46 | 1.840 |
Why?
|
| Athletes | 10 | 2023 | 52 | 1.800 |
Why?
|
| Suture Techniques | 15 | 2023 | 105 | 1.790 |
Why?
|
| Pain | 20 | 2023 | 327 | 1.790 |
Why?
|
| Bankart Lesions | 4 | 2023 | 13 | 1.750 |
Why?
|
| Ulnar Collateral Ligament Reconstruction | 5 | 2023 | 17 | 1.710 |
Why?
|
| Recovery of Function | 20 | 2019 | 246 | 1.670 |
Why?
|
| Surgeons | 4 | 2023 | 79 | 1.560 |
Why?
|
| Arm | 15 | 2022 | 68 | 1.520 |
Why?
|
| Internship and Residency | 3 | 2020 | 205 | 1.470 |
Why?
|
| Patient Readmission | 10 | 2021 | 117 | 1.440 |
Why?
|
| Allografts | 14 | 2023 | 144 | 1.440 |
Why?
|
| Reoperation | 22 | 2021 | 776 | 1.430 |
Why?
|
| Humerus | 11 | 2021 | 87 | 1.410 |
Why?
|
| Menisci, Tibial | 11 | 2022 | 91 | 1.360 |
Why?
|
| Biological Products | 2 | 2023 | 31 | 1.340 |
Why?
|
| Workers' Compensation | 9 | 2021 | 51 | 1.310 |
Why?
|
| Shoulder Pain | 8 | 2020 | 49 | 1.310 |
Why?
|
| Recurrence | 18 | 2021 | 272 | 1.300 |
Why?
|
| Collateral Ligaments | 4 | 2023 | 22 | 1.280 |
Why?
|
| Surveys and Questionnaires | 16 | 2020 | 1038 | 1.240 |
Why?
|
| Ligaments, Articular | 12 | 2023 | 84 | 1.230 |
Why?
|
| Follow-Up Studies | 31 | 2021 | 1441 | 1.210 |
Why?
|
| Acromion | 5 | 2020 | 20 | 1.200 |
Why?
|
| Bone Diseases | 2 | 2019 | 19 | 1.180 |
Why?
|
| Elbow | 9 | 2023 | 40 | 1.170 |
Why?
|
| Return to Work | 6 | 2021 | 38 | 1.140 |
Why?
|
| Computer Simulation | 6 | 2022 | 175 | 1.140 |
Why?
|
| Wound Healing | 11 | 2017 | 113 | 1.140 |
Why?
|
| Arthroplasty, Subchondral | 4 | 2015 | 18 | 1.120 |
Why?
|
| Osteoarthritis, Knee | 9 | 2023 | 295 | 1.110 |
Why?
|
| Shoulder Fractures | 4 | 2021 | 28 | 1.100 |
Why?
|
| Transplantation, Homologous | 17 | 2022 | 195 | 1.080 |
Why?
|
| United States | 23 | 2021 | 1829 | 1.070 |
Why?
|
| Aged, 80 and over | 29 | 2020 | 3783 | 1.070 |
Why?
|
| Prospective Studies | 18 | 2023 | 1523 | 1.030 |
Why?
|
| Clinical Competence | 3 | 2018 | 204 | 0.980 |
Why?
|
| Imaging, Three-Dimensional | 15 | 2021 | 158 | 0.970 |
Why?
|
| Cohort Studies | 17 | 2023 | 1429 | 0.970 |
Why?
|
| Bone Resorption | 4 | 2019 | 79 | 0.960 |
Why?
|
| Fractures, Stress | 2 | 2023 | 16 | 0.940 |
Why?
|
| Platelet-Rich Plasma | 5 | 2021 | 40 | 0.940 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 6 | 2020 | 23 | 0.930 |
Why?
|
| Fracture Fixation, Internal | 5 | 2021 | 57 | 0.920 |
Why?
|
| Acromioclavicular Joint | 2 | 2018 | 14 | 0.910 |
Why?
|
| Patellar Ligament | 5 | 2015 | 33 | 0.910 |
Why?
|
| Arthroplasty, Replacement | 7 | 2016 | 132 | 0.900 |
Why?
|
| Sports | 2 | 2022 | 28 | 0.890 |
Why?
|
| Clavicle | 3 | 2018 | 11 | 0.880 |
Why?
|
| Exercise Therapy | 4 | 2020 | 82 | 0.870 |
Why?
|
| Social Media | 2 | 2022 | 45 | 0.870 |
Why?
|
| Time Factors | 17 | 2020 | 1289 | 0.860 |
Why?
|
| Quality Improvement | 3 | 2020 | 127 | 0.850 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 98 | 0.850 |
Why?
|
| Risk Factors | 22 | 2022 | 1998 | 0.840 |
Why?
|
| Basketball | 2 | 2023 | 7 | 0.830 |
Why?
|
| Postoperative Period | 17 | 2022 | 243 | 0.830 |
Why?
|
| Operative Time | 4 | 2020 | 82 | 0.830 |
Why?
|
| Stress, Mechanical | 7 | 2020 | 134 | 0.830 |
Why?
|
| Rotation | 17 | 2021 | 109 | 0.820 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2021 | 100 | 0.810 |
Why?
|
| Length of Stay | 7 | 2022 | 305 | 0.800 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 33 | 0.790 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 13 | 0.770 |
Why?
|
| Workload | 2 | 2022 | 26 | 0.760 |
Why?
|
| Meniscectomy | 2 | 2019 | 13 | 0.760 |
Why?
|
| Musculoskeletal Manipulations | 1 | 2022 | 5 | 0.750 |
Why?
|
| Pain, Postoperative | 10 | 2022 | 273 | 0.750 |
Why?
|
| Depression | 4 | 2021 | 369 | 0.750 |
Why?
|
| Quality of Life | 10 | 2022 | 560 | 0.740 |
Why?
|
| Activities of Daily Living | 11 | 2022 | 355 | 0.740 |
Why?
|
| Open Fracture Reduction | 1 | 2021 | 5 | 0.730 |
Why?
|
| Tympanoplasty | 1 | 2021 | 1 | 0.730 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2021 | 1 | 0.730 |
Why?
|
| Otitis Media | 1 | 2021 | 3 | 0.730 |
Why?
|
| Anesthesia | 1 | 2022 | 28 | 0.730 |
Why?
|
| Joint Capsule | 4 | 2016 | 36 | 0.730 |
Why?
|
| Football | 4 | 2019 | 21 | 0.720 |
Why?
|
| Wounds and Injuries | 3 | 2019 | 36 | 0.710 |
Why?
|
| Rupture | 14 | 2021 | 79 | 0.710 |
Why?
|
| Fractures, Bone | 3 | 2023 | 69 | 0.690 |
Why?
|
| Muscle Strength | 8 | 2020 | 99 | 0.680 |
Why?
|
| Age Factors | 13 | 2020 | 641 | 0.680 |
Why?
|
| Amputees | 1 | 2020 | 1 | 0.670 |
Why?
|
| Artificial Limbs | 1 | 2020 | 5 | 0.660 |
Why?
|
| Analgesics, Opioid | 7 | 2022 | 210 | 0.650 |
Why?
|
| Patient Satisfaction | 9 | 2021 | 258 | 0.650 |
Why?
|
| Weight Lifting | 1 | 2019 | 8 | 0.620 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2022 | 88 | 0.620 |
Why?
|
| Demography | 1 | 2019 | 58 | 0.620 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2019 | 65 | 0.610 |
Why?
|
| Disability Evaluation | 4 | 2020 | 218 | 0.610 |
Why?
|
| Tendon Transfer | 3 | 2014 | 15 | 0.610 |
Why?
|
| Sutures | 6 | 2023 | 31 | 0.610 |
Why?
|
| Joint Dislocations | 2 | 2019 | 50 | 0.590 |
Why?
|
| Tissue Transplantation | 2 | 2016 | 11 | 0.590 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 19 | 0.590 |
Why?
|
| Cost-Benefit Analysis | 5 | 2022 | 109 | 0.590 |
Why?
|
| Electromyography | 7 | 2021 | 68 | 0.580 |
Why?
|
| Materials Testing | 3 | 2017 | 113 | 0.570 |
Why?
|
| Movement | 3 | 2016 | 104 | 0.570 |
Why?
|
| Surgical Wound Infection | 3 | 2018 | 78 | 0.570 |
Why?
|
| Health Care Costs | 1 | 2018 | 61 | 0.550 |
Why?
|
| Databases, Factual | 11 | 2019 | 314 | 0.550 |
Why?
|
| ROC Curve | 6 | 2020 | 125 | 0.540 |
Why?
|
| Pain Measurement | 14 | 2020 | 418 | 0.540 |
Why?
|
| Simulation Training | 1 | 2018 | 34 | 0.540 |
Why?
|
| Hospitalization | 2 | 2018 | 290 | 0.540 |
Why?
|
| Osteochondritis Dissecans | 2 | 2015 | 15 | 0.530 |
Why?
|
| Leishmaniasis, Visceral | 8 | 2015 | 8 | 0.530 |
Why?
|
| Osteotomy | 5 | 2017 | 121 | 0.530 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 71 | 0.520 |
Why?
|
| Patellofemoral Joint | 3 | 2023 | 45 | 0.520 |
Why?
|
| Algorithms | 6 | 2022 | 314 | 0.520 |
Why?
|
| Electronic Health Records | 1 | 2017 | 66 | 0.520 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2022 | 588 | 0.520 |
Why?
|
| Hyaluronic Acid | 2 | 2021 | 33 | 0.500 |
Why?
|
| Patient Compliance | 1 | 2017 | 145 | 0.500 |
Why?
|
| Random Allocation | 6 | 2020 | 105 | 0.500 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2018 | 251 | 0.480 |
Why?
|
| Decompression, Surgical | 3 | 2012 | 117 | 0.480 |
Why?
|
| Cartilage Diseases | 3 | 2023 | 42 | 0.480 |
Why?
|
| Orthopedic Surgeons | 1 | 2016 | 24 | 0.480 |
Why?
|
| Sex Factors | 9 | 2019 | 391 | 0.480 |
Why?
|
| Osteolysis | 1 | 2016 | 131 | 0.470 |
Why?
|
| Viscosupplementation | 1 | 2015 | 2 | 0.470 |
Why?
|
| Viscosupplements | 1 | 2015 | 4 | 0.470 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 289 | 0.470 |
Why?
|
| Patellar Dislocation | 3 | 2023 | 21 | 0.460 |
Why?
|
| Femoral Neck Fractures | 1 | 2015 | 9 | 0.450 |
Why?
|
| Lacerations | 3 | 2013 | 12 | 0.450 |
Why?
|
| Shoulder Prosthesis | 3 | 2020 | 21 | 0.450 |
Why?
|
| Incidence | 8 | 2022 | 636 | 0.450 |
Why?
|
| Transplantation, Autologous | 10 | 2019 | 98 | 0.440 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 55 | 0.430 |
Why?
|
| Synovial Membrane | 4 | 2019 | 48 | 0.430 |
Why?
|
| Radiography | 11 | 2017 | 536 | 0.420 |
Why?
|
| Health Care Surveys | 1 | 2014 | 62 | 0.420 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 30 | 0.420 |
Why?
|
| Humeral Head | 4 | 2022 | 27 | 0.420 |
Why?
|
| Radiology | 1 | 2013 | 16 | 0.420 |
Why?
|
| Models, Educational | 1 | 2013 | 22 | 0.420 |
Why?
|
| Computer-Assisted Instruction | 1 | 2013 | 19 | 0.410 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 30 | 0.410 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2013 | 9 | 0.410 |
Why?
|
| Blood Transfusion | 5 | 2019 | 58 | 0.410 |
Why?
|
| Thromboembolism | 1 | 2013 | 17 | 0.410 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2013 | 4 | 0.400 |
Why?
|
| Hamstring Muscles | 3 | 2018 | 13 | 0.400 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 774 | 0.400 |
Why?
|
| Leg Injuries | 1 | 2012 | 7 | 0.380 |
Why?
|
| Evidence-Based Medicine | 5 | 2014 | 147 | 0.380 |
Why?
|
| Treatment Failure | 9 | 2020 | 129 | 0.380 |
Why?
|
| Case-Control Studies | 8 | 2019 | 482 | 0.380 |
Why?
|
| Bone Marrow | 2 | 2023 | 62 | 0.370 |
Why?
|
| Odds Ratio | 4 | 2020 | 226 | 0.370 |
Why?
|
| Arm Injuries | 1 | 2012 | 7 | 0.370 |
Why?
|
| Hand Injuries | 2 | 2009 | 11 | 0.360 |
Why?
|
| Child | 17 | 2022 | 1171 | 0.360 |
Why?
|
| Osseointegration | 1 | 2012 | 66 | 0.360 |
Why?
|
| Diagnostic Imaging | 4 | 2016 | 72 | 0.350 |
Why?
|
| Leishmania donovani | 5 | 2013 | 5 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 139 | 0.340 |
Why?
|
| Work Capacity Evaluation | 1 | 2010 | 5 | 0.330 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 254 | 0.330 |
Why?
|
| Prosthesis Failure | 5 | 2014 | 482 | 0.330 |
Why?
|
| Tensile Strength | 4 | 2019 | 19 | 0.330 |
Why?
|
| Patient Discharge | 5 | 2022 | 146 | 0.330 |
Why?
|
| Supervised Machine Learning | 2 | 2020 | 10 | 0.330 |
Why?
|
| Area Under Curve | 2 | 2020 | 60 | 0.320 |
Why?
|
| Animals | 16 | 2022 | 3287 | 0.320 |
Why?
|
| Meniscus | 2 | 2020 | 11 | 0.320 |
Why?
|
| Psychometrics | 2 | 2021 | 177 | 0.320 |
Why?
|
| Pectoralis Muscles | 3 | 2015 | 16 | 0.310 |
Why?
|
| Matched-Pair Analysis | 2 | 2020 | 20 | 0.310 |
Why?
|
| Arthralgia | 6 | 2016 | 95 | 0.310 |
Why?
|
| Nerve Compression Syndromes | 2 | 2009 | 17 | 0.310 |
Why?
|
| Equipment Design | 4 | 2020 | 123 | 0.300 |
Why?
|
| Information Systems | 4 | 2021 | 15 | 0.300 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 594 | 0.300 |
Why?
|
| Rotator Cuff Tear Arthropathy | 2 | 2019 | 12 | 0.300 |
Why?
|
| Bibliometrics | 2 | 2022 | 23 | 0.290 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 57 | 0.290 |
Why?
|
| Physical Examination | 4 | 2017 | 87 | 0.290 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 11 | 0.280 |
Why?
|
| Coracoid Process | 2 | 2018 | 5 | 0.280 |
Why?
|
| Autografts | 4 | 2023 | 20 | 0.280 |
Why?
|
| Transplantation | 1 | 2008 | 3 | 0.280 |
Why?
|
| Prosthesis Design | 3 | 2019 | 449 | 0.280 |
Why?
|
| Synovectomy | 1 | 2007 | 5 | 0.280 |
Why?
|
| Hemiarthroplasty | 4 | 2016 | 31 | 0.280 |
Why?
|
| Injections, Intra-Articular | 5 | 2023 | 56 | 0.280 |
Why?
|
| Humeral Fractures | 2 | 2017 | 20 | 0.270 |
Why?
|
| Hemarthrosis | 1 | 2007 | 22 | 0.270 |
Why?
|
| Lower Extremity | 2 | 2018 | 33 | 0.270 |
Why?
|
| Hemophilia A | 1 | 2007 | 49 | 0.260 |
Why?
|
| India | 6 | 2021 | 16 | 0.260 |
Why?
|
| Severity of Illness Index | 7 | 2020 | 813 | 0.260 |
Why?
|
| Eye Injuries | 2 | 1997 | 2 | 0.260 |
Why?
|
| Propionibacterium acnes | 2 | 2018 | 6 | 0.260 |
Why?
|
| Postoperative Care | 6 | 2020 | 109 | 0.250 |
Why?
|
| Patella | 3 | 2023 | 58 | 0.250 |
Why?
|
| Physical Therapy Modalities | 4 | 2018 | 59 | 0.250 |
Why?
|
| Machine Learning | 3 | 2021 | 59 | 0.250 |
Why?
|
| Chronic Disease | 3 | 2021 | 389 | 0.240 |
Why?
|
| Tissue Banks | 2 | 2018 | 3 | 0.230 |
Why?
|
| Pulmonary Embolism | 2 | 2018 | 57 | 0.230 |
Why?
|
| Reference Values | 4 | 2019 | 167 | 0.230 |
Why?
|
| Meta-Analysis as Topic | 5 | 2015 | 25 | 0.230 |
Why?
|
| Debridement | 4 | 2018 | 67 | 0.220 |
Why?
|
| Regression Analysis | 4 | 2014 | 220 | 0.220 |
Why?
|
| Inpatients | 3 | 2022 | 116 | 0.220 |
Why?
|
| Preoperative Care | 3 | 2020 | 112 | 0.220 |
Why?
|
| Time-to-Treatment | 2 | 2015 | 28 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2023 | 382 | 0.220 |
Why?
|
| Thigh | 3 | 2018 | 26 | 0.210 |
Why?
|
| Age Distribution | 5 | 2016 | 71 | 0.210 |
Why?
|
| Radiostereometric Analysis | 1 | 2023 | 6 | 0.210 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2020 | 19 | 0.200 |
Why?
|
| Muscle Weakness | 1 | 2023 | 27 | 0.200 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2023 | 6 | 0.200 |
Why?
|
| Fascia Lata | 1 | 2023 | 6 | 0.200 |
Why?
|
| Access to Information | 1 | 2022 | 6 | 0.200 |
Why?
|
| Preoperative Period | 2 | 2020 | 64 | 0.190 |
Why?
|
| Benzophenones | 2 | 2019 | 21 | 0.190 |
Why?
|
| Ketones | 2 | 2019 | 19 | 0.190 |
Why?
|
| Shoulder Impingement Syndrome | 2 | 2014 | 10 | 0.190 |
Why?
|
| Polymers | 2 | 2019 | 37 | 0.190 |
Why?
|
| Early Ambulation | 2 | 2020 | 16 | 0.190 |
Why?
|
| Tenotomy | 2 | 2021 | 14 | 0.190 |
Why?
|
| Polyethylene Glycols | 2 | 2019 | 37 | 0.190 |
Why?
|
| Ilium | 2 | 2014 | 27 | 0.190 |
Why?
|
| Clinical Protocols | 2 | 2020 | 54 | 0.190 |
Why?
|
| Video Recording | 2 | 2020 | 29 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2021 | 251 | 0.190 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 32 | 0.190 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2021 | 1 | 0.180 |
Why?
|
| Equipment Failure | 3 | 2017 | 35 | 0.180 |
Why?
|
| Neurological Rehabilitation | 1 | 2021 | 5 | 0.180 |
Why?
|
| Quadriplegia | 1 | 2021 | 8 | 0.180 |
Why?
|
| Skin | 2 | 2019 | 119 | 0.180 |
Why?
|
| Cartilage | 3 | 2016 | 70 | 0.180 |
Why?
|
| Auditory Threshold | 1 | 2021 | 18 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 35 | 0.180 |
Why?
|
| Bone Plates | 1 | 2021 | 40 | 0.180 |
Why?
|
| Hand | 1 | 2021 | 39 | 0.180 |
Why?
|
| Pressure | 6 | 2015 | 50 | 0.180 |
Why?
|
| Medicine | 1 | 2001 | 8 | 0.180 |
Why?
|
| Specialization | 1 | 2001 | 12 | 0.180 |
Why?
|
| Community-Institutional Relations | 1 | 2001 | 15 | 0.180 |
Why?
|
| Registries | 2 | 2019 | 176 | 0.180 |
Why?
|
| Joint Diseases | 2 | 2020 | 89 | 0.180 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 37 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 38 | 0.170 |
Why?
|
| Joint Prosthesis | 2 | 2013 | 75 | 0.170 |
Why?
|
| Bone Density | 2 | 2019 | 136 | 0.170 |
Why?
|
| Ankle | 1 | 2020 | 19 | 0.170 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 41 | 0.170 |
Why?
|
| Forecasting | 2 | 2019 | 82 | 0.170 |
Why?
|
| Child, Preschool | 6 | 2018 | 578 | 0.170 |
Why?
|
| Perioperative Period | 1 | 2020 | 8 | 0.170 |
Why?
|
| Health Services Accessibility | 1 | 2001 | 104 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 36 | 0.160 |
Why?
|
| Posterior Cruciate Ligament Reconstruction | 1 | 2020 | 6 | 0.160 |
Why?
|
| Analgesia | 1 | 2021 | 34 | 0.160 |
Why?
|
| Ultrasonography | 4 | 2009 | 204 | 0.160 |
Why?
|
| Resistance Training | 1 | 2020 | 2 | 0.160 |
Why?
|
| Restraint, Physical | 1 | 2020 | 8 | 0.160 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 28 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 17 | 0.160 |
Why?
|
| Efficiency | 1 | 2020 | 20 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2020 | 16 | 0.160 |
Why?
|
| Body Height | 4 | 2015 | 31 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 34 | 0.160 |
Why?
|
| Muscle Fatigue | 2 | 2017 | 8 | 0.160 |
Why?
|
| Research Subjects | 1 | 2019 | 9 | 0.160 |
Why?
|
| Logistic Models | 1 | 2020 | 358 | 0.160 |
Why?
|
| Bacteria | 1 | 2019 | 61 | 0.150 |
Why?
|
| Transplants | 2 | 2016 | 9 | 0.150 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 42 | 0.150 |
Why?
|
| Models, Biological | 3 | 2013 | 306 | 0.150 |
Why?
|
| Patient Positioning | 2 | 2018 | 34 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2019 | 52 | 0.150 |
Why?
|
| Time | 1 | 2019 | 14 | 0.150 |
Why?
|
| Corneal Opacity | 1 | 1999 | 1 | 0.150 |
Why?
|
| Osteosarcoma, Juxtacortical | 1 | 1999 | 1 | 0.150 |
Why?
|
| Femoral Neoplasms | 1 | 1999 | 4 | 0.150 |
Why?
|
| Keratoplasty, Penetrating | 1 | 1999 | 9 | 0.150 |
Why?
|
| Mental Health | 1 | 2020 | 96 | 0.150 |
Why?
|
| Propensity Score | 1 | 2019 | 35 | 0.150 |
Why?
|
| Orbital Neoplasms | 1 | 1999 | 6 | 0.150 |
Why?
|
| Anemia | 1 | 2019 | 30 | 0.150 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 35 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 363 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 124 | 0.150 |
Why?
|
| Motivation | 1 | 2019 | 84 | 0.150 |
Why?
|
| Dyspnea | 1 | 2019 | 36 | 0.150 |
Why?
|
| Rabbits | 3 | 2015 | 168 | 0.150 |
Why?
|
| Intra-Articular Fractures | 1 | 2018 | 12 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2012 | 14 | 0.150 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 51 | 0.150 |
Why?
|
| Weight-Bearing | 5 | 2016 | 131 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2017 | 565 | 0.140 |
Why?
|
| Doxycycline | 1 | 2018 | 15 | 0.140 |
Why?
|
| Pudendal Nerve | 1 | 2018 | 3 | 0.140 |
Why?
|
| Soccer | 1 | 2018 | 13 | 0.140 |
Why?
|
| Joint Capsule Release | 1 | 2018 | 7 | 0.140 |
Why?
|
| Bursitis | 1 | 2018 | 8 | 0.140 |
Why?
|
| Operating Rooms | 1 | 2018 | 11 | 0.140 |
Why?
|
| Sepsis | 1 | 2019 | 112 | 0.140 |
Why?
|
| Patient Selection | 3 | 2021 | 171 | 0.140 |
Why?
|
| Leishmaniasis, Cutaneous | 2 | 2012 | 2 | 0.140 |
Why?
|
| Models, Animal | 3 | 2015 | 100 | 0.140 |
Why?
|
| Michigan | 1 | 2017 | 17 | 0.140 |
Why?
|
| Disease Management | 1 | 2018 | 102 | 0.140 |
Why?
|
| Pneumonia | 1 | 2018 | 69 | 0.140 |
Why?
|
| Fever | 1 | 2017 | 32 | 0.140 |
Why?
|
| Reimbursement, Incentive | 1 | 2017 | 7 | 0.140 |
Why?
|
| Hospital Charges | 1 | 2017 | 15 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 452 | 0.130 |
Why?
|
| Osteoporosis | 1 | 2018 | 72 | 0.130 |
Why?
|
| Heart Failure | 1 | 2019 | 141 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 110 | 0.130 |
Why?
|
| Interinstitutional Relations | 1 | 2017 | 11 | 0.130 |
Why?
|
| Patient Preference | 1 | 2017 | 32 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 25 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 11 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 442 | 0.130 |
Why?
|
| Hyaline Cartilage | 2 | 2013 | 7 | 0.130 |
Why?
|
| Comorbidity | 4 | 2019 | 431 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 17 | 0.120 |
Why?
|
| Hyphema | 1 | 1996 | 1 | 0.120 |
Why?
|
| Trabeculectomy | 1 | 1996 | 1 | 0.120 |
Why?
|
| Anterior Chamber | 1 | 1996 | 2 | 0.120 |
Why?
|
| Knee | 3 | 2023 | 38 | 0.120 |
Why?
|
| Cornea | 1 | 1996 | 9 | 0.120 |
Why?
|
| Muscle Strength Dynamometer | 2 | 2013 | 12 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1996 | 6 | 0.120 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2013 | 7 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 39 | 0.120 |
Why?
|
| Biomarkers | 2 | 2015 | 487 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 1 | 2018 | 179 | 0.120 |
Why?
|
| Deltoid Muscle | 1 | 2015 | 5 | 0.120 |
Why?
|
| Synovial Fluid | 2 | 2015 | 89 | 0.120 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 83 | 0.120 |
Why?
|
| Liver Abscess, Amebic | 1 | 1995 | 1 | 0.120 |
Why?
|
| Capsaicin | 1 | 2015 | 8 | 0.120 |
Why?
|
| Developing Countries | 1 | 1995 | 13 | 0.120 |
Why?
|
| Chondrogenesis | 1 | 2015 | 24 | 0.120 |
Why?
|
| Visual Analog Scale | 3 | 2020 | 41 | 0.120 |
Why?
|
| Hypertriglyceridemia | 1 | 2015 | 20 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 17 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 28 | 0.110 |
Why?
|
| Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 3 | 0.110 |
Why?
|
| Thorax | 1 | 2014 | 10 | 0.110 |
Why?
|
| Tissue Donors | 2 | 2009 | 63 | 0.110 |
Why?
|
| Torque | 2 | 2017 | 18 | 0.110 |
Why?
|
| Athletic Performance | 1 | 2014 | 15 | 0.110 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 216 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 197 | 0.110 |
Why?
|
| Rural Population | 2 | 2006 | 21 | 0.100 |
Why?
|
| Publishing | 1 | 2014 | 31 | 0.100 |
Why?
|
| Learning Curve | 1 | 2013 | 15 | 0.100 |
Why?
|
| Swine | 4 | 2009 | 67 | 0.100 |
Why?
|
| Hip | 1 | 2013 | 28 | 0.100 |
Why?
|
| CD58 Antigens | 1 | 2013 | 1 | 0.100 |
Why?
|
| Numbers Needed To Treat | 1 | 2013 | 1 | 0.100 |
Why?
|
| Visual Acuity | 3 | 1999 | 38 | 0.100 |
Why?
|
| Surgical Instruments | 1 | 2013 | 24 | 0.100 |
Why?
|
| Trypanocidal Agents | 1 | 2012 | 1 | 0.100 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 5 | 0.100 |
Why?
|
| Spleen | 1 | 2012 | 29 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2012 | 21 | 0.100 |
Why?
|
| Infant | 4 | 2018 | 486 | 0.100 |
Why?
|
| Braces | 2 | 2016 | 21 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 26 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 33 | 0.090 |
Why?
|
| Arthrography | 2 | 2015 | 23 | 0.090 |
Why?
|
| Sterilization | 1 | 2012 | 7 | 0.090 |
Why?
|
| Gamma Rays | 1 | 2012 | 12 | 0.090 |
Why?
|
| Tissue Preservation | 1 | 2012 | 2 | 0.090 |
Why?
|
| Elasticity | 2 | 2009 | 25 | 0.090 |
Why?
|
| Ankle Joint | 1 | 2012 | 38 | 0.090 |
Why?
|
| Graft Survival | 1 | 2012 | 84 | 0.090 |
Why?
|
| Body Mass Index | 3 | 2020 | 384 | 0.090 |
Why?
|
| Endemic Diseases | 3 | 2006 | 7 | 0.090 |
Why?
|
| Survivorship | 2 | 2021 | 13 | 0.090 |
Why?
|
| Skilled Nursing Facilities | 2 | 2021 | 27 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 155 | 0.080 |
Why?
|
| Reference Standards | 1 | 2010 | 22 | 0.080 |
Why?
|
| Occupations | 1 | 2010 | 13 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2010 | 56 | 0.080 |
Why?
|
| Cushing Syndrome | 1 | 2010 | 2 | 0.080 |
Why?
|
| Medical Errors | 1 | 2009 | 27 | 0.080 |
Why?
|
| Freezing | 1 | 2009 | 11 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 72 | 0.080 |
Why?
|
| Outpatients | 2 | 2021 | 54 | 0.080 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2009 | 14 | 0.070 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 59 | 0.070 |
Why?
|
| Medicare | 2 | 2021 | 108 | 0.070 |
Why?
|
| Prognosis | 3 | 2019 | 740 | 0.070 |
Why?
|
| Papua New Guinea | 2 | 1999 | 2 | 0.070 |
Why?
|
| Antiprotozoal Agents | 2 | 2013 | 8 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 210 | 0.070 |
Why?
|
| Neurosurgical Procedures | 1 | 2009 | 140 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 293 | 0.070 |
Why?
|
| Prevalence | 3 | 2015 | 384 | 0.060 |
Why?
|
| Smoking | 2 | 2019 | 168 | 0.060 |
Why?
|
| Hindlimb | 1 | 2006 | 15 | 0.060 |
Why?
|
| Wuchereria bancrofti | 1 | 2006 | 1 | 0.060 |
Why?
|
| Elephantiasis, Filarial | 1 | 2006 | 2 | 0.060 |
Why?
|
| Hypericum | 1 | 2005 | 3 | 0.060 |
Why?
|
| Traction | 1 | 2005 | 26 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2017 | 54 | 0.060 |
Why?
|
| Arthrometry, Articular | 2 | 2017 | 7 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 36 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2016 | 64 | 0.060 |
Why?
|
| Health Status Indicators | 3 | 2010 | 67 | 0.050 |
Why?
|
| Ligaments | 1 | 2023 | 10 | 0.050 |
Why?
|
| Absorbable Implants | 2 | 2014 | 16 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 22 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2022 | 22 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2022 | 6 | 0.050 |
Why?
|
| Posture | 2 | 2015 | 56 | 0.050 |
Why?
|
| Polyethylene | 2 | 2015 | 116 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 21 | 0.050 |
Why?
|
| Models, Anatomic | 2 | 2013 | 33 | 0.040 |
Why?
|
| Network Meta-Analysis | 1 | 2021 | 22 | 0.040 |
Why?
|
| Allopurinol | 1 | 2001 | 3 | 0.040 |
Why?
|
| Pentamidine | 1 | 2001 | 2 | 0.040 |
Why?
|
| Northern Territory | 1 | 2001 | 1 | 0.040 |
Why?
|
| Culture | 1 | 2001 | 23 | 0.040 |
Why?
|
| Medicaid | 1 | 2021 | 34 | 0.040 |
Why?
|
| Femoral Nerve | 1 | 2021 | 9 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 23 | 0.040 |
Why?
|
| Parasitemia | 1 | 2000 | 1 | 0.040 |
Why?
|
| Dermis | 1 | 2020 | 8 | 0.040 |
Why?
|
| Psychodidae | 1 | 2000 | 1 | 0.040 |
Why?
|
| DNA Probes | 1 | 2000 | 7 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2001 | 81 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 85 | 0.040 |
Why?
|
| Calibration | 1 | 2020 | 16 | 0.040 |
Why?
|
| Epiphyses | 1 | 2020 | 8 | 0.040 |
Why?
|
| Musculoskeletal Pain | 1 | 2020 | 19 | 0.040 |
Why?
|
| Quality Control | 1 | 2020 | 25 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2020 | 30 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2019 | 17 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 140 | 0.040 |
Why?
|
| Morphine | 1 | 2020 | 70 | 0.040 |
Why?
|
| Rehabilitation | 1 | 2019 | 11 | 0.040 |
Why?
|
| Hematocrit | 1 | 2019 | 13 | 0.040 |
Why?
|
| Episode of Care | 1 | 2019 | 5 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2019 | 22 | 0.040 |
Why?
|
| Eyelid Neoplasms | 1 | 1999 | 3 | 0.040 |
Why?
|
| Conjunctival Neoplasms | 1 | 1999 | 2 | 0.040 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1999 | 2 | 0.040 |
Why?
|
| Pupil | 1 | 1999 | 3 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 43 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 17 | 0.040 |
Why?
|
| Software | 1 | 2019 | 50 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 59 | 0.040 |
Why?
|
| Dissection | 1 | 2018 | 22 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2018 | 21 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 169 | 0.030 |
Why?
|
| Survival Rate | 1 | 1999 | 323 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 322 | 0.030 |
Why?
|
| Hockey | 1 | 2017 | 2 | 0.030 |
Why?
|
| Blindness | 1 | 1997 | 9 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2017 | 8 | 0.030 |
Why?
|
| Tarsal Bones | 1 | 2016 | 3 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 11 | 0.030 |
Why?
|
| Torso | 1 | 2017 | 6 | 0.030 |
Why?
|
| Online Systems | 1 | 2016 | 2 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 1996 | 1 | 0.030 |
Why?
|
| Proprioception | 1 | 2016 | 18 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 1996 | 8 | 0.030 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 25 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 16 | 0.030 |
Why?
|
| Blood | 1 | 1996 | 17 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2016 | 97 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2016 | 42 | 0.030 |
Why?
|
| Medical Illustration | 1 | 2015 | 11 | 0.030 |
Why?
|
| Photography | 1 | 2015 | 11 | 0.030 |
Why?
|
| Surgical Tape | 1 | 2015 | 3 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 30 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 8 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 114 | 0.030 |
Why?
|
| Parasite Load | 1 | 2015 | 1 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 14 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 22 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 102 | 0.030 |
Why?
|
| Chemokine CCL19 | 1 | 2015 | 3 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 74 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2016 | 96 | 0.030 |
Why?
|
| Fibrocartilage | 1 | 2015 | 5 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2015 | 119 | 0.030 |
Why?
|
| Occupational Injuries | 1 | 2015 | 6 | 0.030 |
Why?
|
| Global Health | 1 | 2015 | 31 | 0.030 |
Why?
|
| Denmark | 1 | 2014 | 9 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 61 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 129 | 0.030 |
Why?
|
| Authorship | 1 | 2014 | 12 | 0.030 |
Why?
|
| Liver | 1 | 1995 | 142 | 0.030 |
Why?
|
| Conflict of Interest | 1 | 2014 | 10 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 285 | 0.030 |
Why?
|
| Metals | 1 | 2014 | 135 | 0.030 |
Why?
|
| Acellular Dermis | 1 | 2013 | 6 | 0.030 |
Why?
|
| Amphotericin B | 1 | 2013 | 5 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2014 | 56 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 233 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2013 | 8 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 8 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 93 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 64 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 178 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 168 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 96 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2012 | 9 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 99 | 0.020 |
Why?
|
| Contraindications | 1 | 2012 | 26 | 0.020 |
Why?
|
| Gait | 1 | 2016 | 382 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 85 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 246 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2012 | 49 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 88 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 106 | 0.020 |
Why?
|
| Body Weight | 2 | 2009 | 129 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 235 | 0.020 |
Why?
|
| Neurocysticercosis | 1 | 2010 | 1 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2010 | 24 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 75 | 0.020 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2009 | 14 | 0.020 |
Why?
|
| Prosthesis Fitting | 1 | 2009 | 19 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 125 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2009 | 7 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 84 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 113 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 1236 | 0.020 |
Why?
|
| Parents | 1 | 2010 | 107 | 0.020 |
Why?
|
| Culex | 1 | 2006 | 1 | 0.020 |
Why?
|
| Insect Vectors | 1 | 2006 | 1 | 0.020 |
Why?
|
| Microfilariae | 1 | 2006 | 2 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2005 | 1 | 0.020 |
Why?
|
| Agglutination Tests | 1 | 2005 | 4 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2005 | 3 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 12 | 0.020 |
Why?
|
| Axillary Vein | 1 | 2005 | 1 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2005 | 52 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2005 | 12 | 0.010 |
Why?
|
| Selection Bias | 1 | 2005 | 6 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2005 | 42 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 380 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 540 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 525 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 1200 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 161 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 116 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2000 | 18 | 0.010 |
Why?
|
| Digoxigenin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 2000 | 9 | 0.010 |
Why?
|
| Biopsy | 1 | 2000 | 192 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1977 | 109 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1977 | 13 | 0.000 |
Why?
|
| Health Surveys | 1 | 1977 | 79 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1977 | 99 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1977 | 94 | 0.000 |
Why?
|
| Mass Screening | 1 | 1977 | 167 | 0.000 |
Why?
|